Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke

BACKGROUND: There is currently only one clinically approved drug, tissue plasminogen activator (tPA), for the treatment of acute ischaemic stroke. The RhoA pathway, including RhoA and its downstream effector Rho kinase (ROCK), has been identified as a possible therapeutic target. Our aim was to asse...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Vesterinen, Hanna M, Currie, Gillian L, Carter, Samantha, Mee, Sarah, Watzlawick, Ralf, Egan, Kieren J, Macleod, Malcolm R, Sena, Emily S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3665471/
https://ncbi.nlm.nih.gov/pubmed/23687965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-2-33
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia